alpha glucosidase inhibitors (Tianjin University of Science and Technology/Tianjin Medical University/Universite Pierre et Marie Curie)

N/A

Report date: 2025/03/14 16:54:05
NME

Base Information

Drug Namealpha glucosidase inhibitors (Tianjin University of Science and Technology/Tianjin Medical University/Universite Pierre et Marie Curie)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMaltase-glucoamylase inhibitors
TargetsMaltase-glucoamylase
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFranceMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesTianjin University of Science and Technology
China Registration ClassN/A

Develop Information

Active CompaniesTianjin University of Science and TechnologyUniversite Pierre Et Marie CurieTianjin Medical University
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A